Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Plain English summary Patients with chronic rhinosinusitis (CRS) often have blocked or runny noses, and loss of sense of smell. They can also have sac-like growths in their nose called nasal polyps, which often require surgical removement. The symptoms of CRS with nasal polyps can affect quality of...

Full description

Bibliographic Details
Main Authors: Wytske Fokkens, Andrew Trigg, Stella E. Lee, Robert H. Chan, Zuzana Diamant, Claire Hopkins, Peter Howarth, Valerie Lund, Bhabita Mayer, Ana R. Sousa, Steve Yancey, Maggie Tabberer, SYNAPSE study group
Format: Article
Language:English
Published: SpringerOpen 2023-01-01
Series:Journal of Patient-Reported Outcomes
Subjects:
SNOT-22
VAS
Chronic rhinosinusitis with nasal polyps
Psychometric
Efficacy
Quality of life
Online Access:https://doi.org/10.1186/s41687-023-00543-5

Internet

https://doi.org/10.1186/s41687-023-00543-5

Similar Items